3.2 DSM-5-TR Diagnostic Criteria for Substance Use Disorders
Key Takeaways
- The DSM-5-TR organizes 11 Substance Use Disorder (SUD) diagnostic criteria across 4 clinical groupings: Impaired Control, Social Impairment, Risky Use, and Pharmacological Criteria.
- SUD severity is graded by the cumulative number of criteria met within a 12-month period: Mild (2-3 criteria), Moderate (4-5 criteria), and Severe (6 or more criteria).
- Tolerance and withdrawal criteria do NOT count toward an SUD diagnosis when prescribed medications (e.g., opioids, sedatives, stimulants) are taken solely under appropriate medical supervision.
- Diagnostic specifiers include Remission status (Early Remission: 3-12 months without criteria except craving; Sustained Remission: 12+ months) and Environmental/Therapeutic context (In a Controlled Environment, On Maintenance Therapy).
- Master-level clinicians must recognize substance-specific diagnostic variations, such as the absence of a formal withdrawal criterion for Hallucinogen and Inhalant Use Disorders in DSM-5-TR.
3.2 DSM-5-TR Diagnostic Criteria for Substance Use Disorders
Quick Summary: The diagnostic framework for addiction medicine underwent a major paradigm shift with the publication of the DSM-5 and its subsequent Text Revision, the DSM-5-TR. Previous diagnostic manuals (DSM-IV-TR) divided substance problems into two distinct categories: Substance Abuse (viewed as a milder, non-dependent pattern) and Substance Dependence (viewed as a severe physiological illness). The DSM-5-TR eliminated this artificial dichotomy, replacing it with a single, comprehensive diagnostic entity: Substance Use Disorder (SUD), measured along a continuum of mild, moderate, or severe intensity.
Evolution of Addiction Diagnosis: From DSM-IV-TR to DSM-5-TR
The transition to DSM-5-TR addressed major psychometric and clinical limitations of the legacy DSM-IV-TR framework:
- Elimination of Category Overlap: DSM-IV-TR criteria for Substance Abuse and Dependence created diagnostic confusion (e.g., a client could meet criteria for Dependence without ever meeting criteria for Abuse).
- Removal of Legal Problems Criterion: The DSM-IV Abuse criterion regarding "recurrent substance-related legal problems" was removed due to severe socio-demographic bias, variable law enforcement practices, and poor psychometric fit within unidimensional severity models.
- Addition of Craving Criterion: DSM-5-TR introduced Craving (strong desire or urge to use) as a core criterion, reflecting modern neurobiological research on cue-reactivity, limbic system activation, and relapse vulnerability.
To establish a DSM-5-TR diagnosis of a Substance Use Disorder, a client must exhibit a problematic pattern of substance use leading to clinically significant impairment or distress, as manifested by at least 2 out of 11 diagnostic criteria occurring within a 12-month period.
Detailed Analysis of the 11 Diagnostic Criteria across 4 Groupings
The 11 criteria are logically organized into four primary behavioral, social, and physiological groupings:
Group 1: Impaired Control (Criteria 1–4)
- Criterion 1 (Larger Amounts / Longer Duration): The substance is often taken in larger amounts or over a longer period than was originally intended by the individual.
- Criterion 2 (Unsuccessful Cut-Down Efforts): There is a persistent desire or unsuccessful efforts to cut down, reduce, or control substance use despite recognizing its harmful consequences.
- Criterion 3 (Excessive Time Spent): A great deal of time is spent in activities necessary to obtain the substance (e.g., visiting multiple doctors, driving long distances), use the substance (e.g., chain-smoking, binge drinking), or recover from its physiological effects.
- Criterion 4 (Craving): Craving, or a strong desire or urge to use the specific substance. Manifests as intrusive cognitive preoccupation, automatic thoughts, or physiological arousal when exposed to drug-associated cues or environmental triggers.
Group 2: Social Impairment (Criteria 5–7)
- Criterion 5 (Failure to Fulfill Major Obligations): Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home (e.g., repeated absences, poor work performance, suspensions, neglect of children or household duties).
- Criterion 6 (Continued Use Despite Social Problems): Continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance (e.g., arguments with spouse about intoxication, domestic altercations, loss of friendships).
- Criterion 7 (Important Activities Given Up): Important social, occupational, or recreational activities are given up or significantly reduced because of substance use (e.g., withdrawing from family gatherings, hobbies, sports, or professional organizations).
Group 3: Risky Use (Criteria 8–9)
- Criterion 8 (Physically Hazardous Use): Recurrent substance use in situations in which it is physically hazardous (e.g., driving an automobile, operating heavy machinery, swimming, or operating equipment while intoxicated).
- Criterion 9 (Use Despite Physical/Psychological Knowledge): Substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance (e.g., continued drinking despite alcoholic liver cirrhosis, continued cocaine use despite severe hypertension, or continued cannabis use despite anxiety attacks).
Group 4: Pharmacological Criteria (Criteria 10–11)
- Criterion 10 (Tolerance): Defined by either (a) a need for markedly increased amounts of the substance to achieve intoxication or desired effect, or (b) a markedly diminished effect with continued use of the same amount of the substance.
- Criterion 11 (Withdrawal): Defined by either (a) the characteristic withdrawal syndrome for the specific substance (as outlined in DSM-5-TR criteria for specific substance withdrawal), or (b) the substance (or a closely related substance) is taken to relieve or avoid withdrawal symptoms.
CRITICAL CLINICAL EXEMPTION RULE: Criteria 10 (Tolerance) and Criterion 11 (Withdrawal) ARE NOT COUNTED toward a Substance Use Disorder diagnosis for individuals who are taking prescribed medications (such as opioids, stimulants, sedatives, or analgesics) solely under appropriate medical supervision.
Severity Thresholds, Diagnostic Coding, & Clinical Scoring Table
Diagnostic severity is graded strictly by the cumulative number of criteria met within the preceding 12 months:
| Severity Designation | Criteria Count Threshold | Typical Clinical Presentation & Care Implications |
|---|---|---|
| Sub-Threshold / No SUD | 0 – 1 Criterion | Does not meet formal diagnostic threshold. May warrant brief preventive intervention or monitoring. |
| Mild SUD | 2 – 3 Criteria | Presence of mild functional impairment, early impaired control, or risky consumption patterns. Typically managed in outpatient settings. |
| Moderate SUD | 4 – 5 Criteria | Clear social impairment, escalating risky use, and moderate loss of control. Often requires Intensive Outpatient (IOP) or structured care. |
| Severe SUD | 6 or more Criteria | Severe physiological dependence, profound loss of control, extensive social disruption, and severe medical/psychiatric risks. Warrants intensive residential or inpatient care. |
Course Specifiers & Environmental Status
DSM-5-TR incorporates precise specifiers to designate the client's current clinical status and therapeutic environment:
1. Remission Specifiers
- Early Remission: Applied when a client previously met full criteria for a Substance Use Disorder, but has met NO criteria for at least 3 months but less than 12 months (with the single exception that Criterion 4, Craving, may still be present).
- Sustained Remission: Applied when a client previously met full criteria, but has met NO criteria for 12 months or longer (with the single exception that Criterion 4, Craving, may still be present).
2. Contextual & Treatment Specifiers
- In a Controlled Environment: Applied if the client is in an environment where access to alcohol or substances is strictly restricted (e.g., locked inpatient detoxification unit, residential treatment center, secure correctional facility, or therapeutic community).
- On Maintenance Therapy: Applied if the client is taking a prescribed agonist, partial agonist, or antagonist medication as part of Medication-Assisted Treatment (MAT / MAR) for their disorder (e.g., methadone or buprenorphine maintenance for Opioid Use Disorder, naltrexone for Alcohol Use Disorder, or nicotine replacement for Tobacco Use Disorder).
Substance-Class Specific Nuances & Diagnostic Variations
DSM-5-TR applies the SUD criteria across 10 distinct substance classes:
- Alcohol
- Cannabis
- Phencyclidine (PCP) & Other Hallucinogens
- Inhalants
- Opioids
- Sedatives, Hypnotics, or Anxiolytics
- Stimulants (Amphetamine-type substances, Cocaine)
- Tobacco
- Other (or Unknown) Substances
- Non-Substance Behavioral Addiction: Gambling Disorder
Key Diagnostic Exceptions on the MAC Exam
- Hallucinogen Use Disorder & Inhalant Use Disorder: Do NOT include a formal withdrawal criterion (Criterion 11) in DSM-5-TR due to the absence of a medically established physiological withdrawal syndrome for these substance classes.
- Caffeine: DSM-5-TR includes Caffeine Intoxication and Caffeine Withdrawal, but does NOT recognize a formal Caffeine Use Disorder diagnosis in the main clinical manual (placed in Section III for further study).
A client evaluated by a Master Addiction Counselor reports that over the past 12 months, they have repeatedly tried to stop drinking alcohol without success, spend excessive time recovering from hangovers, have driven under the influence twice, and continue drinking despite knowing it worsens their depression. They do not experience tolerance or withdrawal. How should the counselor categorize the severity of this client's Alcohol Use Disorder under DSM-5-TR?
Which of the following statements correctly describes the DSM-5-TR rule regarding pharmacological criteria (tolerance and withdrawal) when diagnosing a Substance Use Disorder?
A client with severe Opioid Use Disorder has been residing in a residential treatment facility for 5 months. During this time, they have taken prescribed buprenorphine/naloxone daily and have not met any DSM-5-TR criteria for Opioid Use Disorder (except craving). What is the correct diagnostic specifier designation for this client?
Which two substance use disorder categories in DSM-5-TR do NOT include a formal withdrawal criterion?